Clinical placebo-controlled study proves the effectiveness of the Antinitus tinnitus patch

Antinitus tinnitus patch Placebo study

The Swedish tinnitus patch, Antinitus, has undergone a clinical, placebo-controlled study, the results of which prove the positive effect of the tinnitus treatment.

A study group of 82 people, suffering from tinnitus, participated in a study during 2016/2017 aimed at comparing the clinical effect of the Antinitus tinnitus patch with a placebo. The study was conducted by physicians at Sickla Ear, Nose, and Throat Centre in Stockholm, Sweden and at the City Hospital in Gothenburg, Sweden.

Results and conclusions of the study

  • The group treated with the Antinitus patch reported significant and statistically assured better results compared to the placebo group.
  • The study establishes that Antinitus is a safe method without the risk of serious complications or adverse effects.

“ The new clinical study results in increased medical evidence for Antinitus. It also supports previously conducted clinical studies and indicates statistically assured significance compared to the placebo. The study is a milestone for us at Sensori and a result of many years of major investments in research and clinical development. We look forward to publishing the results in full shortly ”, says Torbjörn Kemper, CEO, Antinitus.

The placebo study is part of Antinitus’ clinical development programme. The results are currently being compiled and will be published later in 2017. Two studies have previously been conducted, learn more about them here.

“ The result of the study opens up to a number of commercial opportunities for Antinitus, such as new international distribution and partner agreements. The demand for effective forms of treatment is enormous. 10–15 percent of the world’s population suffers from tinnitus and the market potential for our patch is approximately 560 million people. Ease of use in combination with the absence of adverse effects and other risks make Antinitus very suitable for the OTC market ”, says Tommy Rönngren, Chairman of the Board at Antinitus AB.

About Antinitus
Antinitus® is a Swedish innovation in the form of a crescent-shaped patch that can relieve the discomfort of tinnitus. The skin-friendly patch is applied behind the ear and is very easy to use. The treatment period is three weeks and the patch is replaced every day for hygienic reasons. The patch releases no substances or medications and one can live a completely normal life during the course of treatment.

© 2017 Antinitus AB